Latest Refining News

True North Copper has successfully recapitalised following voluntary administration, securing a strong balance sheet and pivoting to an aggressive exploration strategy at its key Queensland copper projects.

First Au Limited updates on its Victorian and Western Australian gold exploration projects, announces key board changes, and completes a $325,000 capital raise to support ongoing operations.

Rubix Resources has identified significant untested chargeability anomalies at its Paperbark project, submitting applications for co-funding to drill these promising targets while progressing exploration across its diversified portfolio.

Ionic Rare Earths reports strong progress on its Belfast rare earth oxide recycling facility, backed by a robust feasibility study and UK government grant applications, alongside strategic developments in Brazil and Uganda.

Wide Open Agriculture reports a 50% reduction in overheads alongside the development of a novel lupin-based tofu product, positioning itself for growth in the global plant protein market.

Great Divide Mining Ltd has taken a decisive step towards gold production by securing a binding farm-in agreement for the historic Adelong Gold Mine, while promising exploration results at its Queensland projects signal further growth potential.

Terra Metals reports robust drilling results from its Dante Project, revealing high-grade titanium alongside copper, PGMs, and vanadium, while securing an option to expand its tenement holdings.

XTC Lithium's latest quarterly report reveals significant gold and lithium anomalies from an extensive auger drilling program at its Southern Cross project, highlighting promising exploration potential.

Tolu Minerals reports significant progress in recommencing production and expanding resources at its Tolukuma mine, underpinned by strategic hires and advanced geophysical surveys.

Audio Pixels Holdings Limited reports significant technical progress in its Digital Sound Reconstruction technology and secures additional funding through convertible notes, while continuing to navigate ASX suspension challenges.

Arovella Therapeutics has bolstered its financial position with a $20 million placement, fully funding the Phase 1 clinical trial of its lead CAR-iNKT therapy, ALA-101, targeting CD19-positive blood cancers. The company also established a Clinical Advisory Board and anticipates key regulatory and clinical milestones in 2025.

Marquee Resources delivers a robust December quarter update, spotlighting strong drilling results at Redlings Rare Earth Project and a maiden Inferred Mineral Resource Estimate, while advancing exploration across multiple strategic projects.